Medica Holding Co., of Minnetonka, Minn., elected David Tilford to its board.
MedImmune Inc., of Gaithersburg, Md., appointed Lota Zoth senior vice president and chief financial officer and promoted Joan Brandt to vice president of corporate quality control; Michael Cowan to vice president of corporate quality assurance; Christine Dingivan to vice president of clinical development, head of strategic operations; Lori Weiman to vice president of corporate communications; and Peter Young to vice president of information technology.
Metaphore Pharmaceuticals Inc., of Fort Lee, N.J., appointed Per Lindell vice president of corporate development.
MIV Therapeutics Inc., of Vancouver, British Columbia, appointed Wilbert Keon medical adviser and chairman of its scientific advisory board.
NaPro BioTherapeutics Inc., of Boulder, Colo., appointed Valentino Stella, Mitchell Avery, Leslie Gunatilaka, Gunda Georg, Mark Hamann and Charles Swindell to its chemistry advisory board.
Nastech Pharmaceutical Co. Inc., of Bothell, Wash., nominated Myron Holubiak, Leslie Michelson and Gerald Stanewick to its board.
NPS Pharmaceuticals Inc., of Salt Lake City, appointed Margaret Crowley senior director of marketing, David Pierson senior director of sales, and Stephen Morris senior director of medical affairs.
Orchid BioSciences Inc., of Princeton, N.J., appointed James Beery to its board.
Quintiles Transnational Corp., of Research Triangle Park, N.C., appointed David Benditt, Arvinder Kurbaan and Richard Sutton to its advisory panel for its integrated cardiac safety services.